Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark N. Diker currently holds 434,879 shares of CANTEL MEDICAL CORP (CMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark N. Diker has been a net seller of CMD stock. They have purchased $174.1K and sold $4.0M worth of shares.
Mark N. Diker's most recent insider trade was on Jun 2, 2021, when they sold 1,000 shares at $80.59 per share.
Mark N. Diker serves as Executive at CANTEL MEDICAL CORP (CMD). They have executed 116 insider transactions totaling $4.1M over their tenure at the company.
Mark N. Diker holds the position of Executive at CANTEL MEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Mark N. Diker has shown a selling trading pattern, with $174.1K in total purchases and $4.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark N. Diker was on Jun 2, 2021, when they sold $35.0M worth of CMD shares. This transaction involved 434,505 shares at $80.59 per share.
Mark N. Diker currently owns 434,879 shares of CANTEL MEDICAL CORP (CMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark N. Diker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark N. Diker has 116 Form 4 filings on record as an insider at CANTEL MEDICAL CORP.
Set alerts for Mark N. Diker and 40,000+ other insiders.